The pelvic floor diagnostics market is reported to reach a valuation of USD 2.18 billion in 2025 to USD 4.15 billion by 2035. Demand for Pelvic Floor Diagnostics is expected to rise at a CAGR of 6.0% over the forecast period. Anal Manometry Systems is expected to hold 27.9% share in 2025, attributed to their critical role in assessing anal and rectal function. Hospitals will dominate the End User segment with a 67.4% market share, owing to high diagnostic volume with pelvic organ prolapse, urinary incontinence, and fecal incontinence.